Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Type 2 Diabetes and Fatty Liver
NCT02721888Phase 4Terminated
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Jul 2012
- Primary completion
- Oct 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Jul 2012; status: terminated.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02721888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02721888.